Literature DB >> 25768320

Identification of hepatocellular carcinoma-associated hub genes and pathways by integrated microarray analysis.

Fangfeng Liu1, Hongguang Li, Hong Chang, Jianlu Wang, Jun Lu.   

Abstract

AIMS AND
BACKGROUND: Hepatocellular carcinoma (HCC) is a dismal malignancy associated with multiple molecular changes. The purpose of this study was to identify the differentially expressed genes and analyze the biological processes related to HCC. METHODS AND STUDY
DESIGN: Datasets of HCC were obtained from the NCBI Gene Expression Omnibus. Integrated analysis of differentially expressed genes was performed using the INMEX program. Then Gene Ontology enrichment analyses and pathway analysis were performed based on the Gene Ontology website and Kyoto Encyclopedia of Genes and Genomes. A protein-protein interaction network was constructed using the Cytoscape software; the netwerk served to find hub genes for HCC. Real-time RT-PCR was used to validate the microarray data for hub genes.
RESULTS: We identified 273 genes that were differentially expressed in HCC. Gene Ontology enrichment analyses revealed response to cadmium ion, cellular response to cadmium ion, and cellular response to zinc ion for these genes. Pathway analysis showed that significant pathways included fatty acid metabolism, butanoate metabolism, and PPAR signaling pathway. The protein-protein interaction network indicated that CDH1, ECHS1, ACAA1, MT2A, and MYC were important genes which participated in many interactions. Experimental validation of the role of four upregulated genes (ECHS1, ACAA1, MT2A and MYC) in the progression of HCC was carried out.
CONCLUSIONS: Our study displayed genes that were consistently differentially expressed in HCC. The biological pathways and protein-protein interaction networks associated with those genes were also identified. We predicted that CDH1, ECHS1, ACAA1, MT2A, and MYC might be target genes for diagnosing HCC.

Entities:  

Mesh:

Year:  2015        PMID: 25768320     DOI: 10.5301/tj.5000241

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  10 in total

Review 1.  Hepatocellular carcinoma and the risk of occupational exposure.

Authors:  Venerando Rapisarda; Carla Loreto; Michele Malaguarnera; Annalisa Ardiri; Maria Proiti; Giuseppe Rigano; Evelise Frazzetto; Maria Irene Ruggeri; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Vito Emanuele Catania; Isidoro Di Carlo; Adriana Toro; Emanuele Bertino; Dario Mangano; Gaetano Bertino
Journal:  World J Hepatol       Date:  2016-05-08

Review 2.  Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.

Authors:  P Wainwright; E Scorletti; C D Byrne
Journal:  Curr Diab Rep       Date:  2017-04       Impact factor: 4.810

3.  Pan-cancer transcriptome analysis reveals a gene expression signature for the identification of tumor tissue origin.

Authors:  Qinghua Xu; Jinying Chen; Shujuan Ni; Cong Tan; Midie Xu; Lei Dong; Lin Yuan; Qifeng Wang; Xiang Du
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

4.  Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.

Authors:  Lei Zhou; Yanyan Du; Lingqun Kong; Xingyuan Zhang; Qiangpu Chen
Journal:  Onco Targets Ther       Date:  2018-04-04       Impact factor: 4.147

5.  Identification and Validation of Key Genes in Hepatocellular Carcinoma by Bioinformatics Analysis.

Authors:  Jia Wang; Rui Peng; Zheng Zhang; Yixi Zhang; Yuke Dai; Yan Sun
Journal:  Biomed Res Int       Date:  2021-02-23       Impact factor: 3.411

6.  Expression Levels of Three Key Genes CCNB1, CDC20, and CENPF in HCC Are Associated With Antitumor Immunity.

Authors:  Tengfei Si; Zhenlin Huang; Yuanhang Jiang; Abigail Walker-Jacobs; Shaqira Gill; Robert Hegarty; Mohammad Hamza; Shirin Elizabeth Khorsandi; Wayel Jassem; Nigel Heaton; Yun Ma
Journal:  Front Oncol       Date:  2021-09-30       Impact factor: 6.244

Review 7.  The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products.

Authors:  Gaoxuan Shao; Ying Liu; Lu Lu; Guangtao Zhang; Wenjun Zhou; Tao Wu; Lei Wang; Hanchen Xu; Guang Ji
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

8.  Comprehensive analysis of key genes, microRNAs and long non-coding RNAs in hepatocellular carcinoma.

Authors:  Baoqi Shi; Xuejun Zhang; Lumeng Chao; Yu Zheng; Yongsheng Tan; Liang Wang; Wei Zhang
Journal:  FEBS Open Bio       Date:  2018-07-31       Impact factor: 2.693

Review 9.  Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.

Authors:  Ozlem Kutlu; Humeyra Nur Kaleli; Ebru Ozer
Journal:  Can J Gastroenterol Hepatol       Date:  2018-08-29

10.  Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma.

Authors:  Sana Raza; Sangam Rajak; Baby Anjum; Rohit A Sinha
Journal:  Hepatoma Res       Date:  2019-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.